Biotinylated Anti-CD19 (Inebilizumab biosimilar)mAb (HDBS0261)
- SKU:
- HDBS0261
- Antibody Type:
- Biotinylated Biosimilar
- Modifications:
- Biotinylated
- Applications:
- SPR
- ELISA
- Drug Development
- Pharmacokinetics
- Disease Area:
- B-Cell Malignancies
- Disease Area:
- Immunotherapy
- Size:
- 100 μg
- Target:
- CD19
- Isotype:
- IgG1
- Host Species:
- Humanized
- Reactivity:
- Human
Description
Product Name: | Biotinylated Anti-CD19 (Inebilizumab biosimilar)mAb |
SKU: | HDBS0261 |
Size: | 100 μg |
Target: | CD19 |
Common Name: | MEDI-551,Medi-551 |
Isotype: | IgG1 |
Host Species: | Humanized |
Reactivity: | Human |
Synonyms: | CD19;4;VID3;GC12802 |
Applications: | ELISA Flow Cyt |
Recommended Dilutions: | ELISA 1:5000-10000; Flow Cyt 1:100 |
Conjugate: | Biotinylated |
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Uniprot: | P15391 |
Formulation & Reconstitution: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions of reconstitution. |
Usage: | Research use only |
Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature. |